Alberto Jimenez Crespo is a Principal and Portfolio Manager at Aristotle Capital Management. Experience in global equity investing has given Mr. Crespo a long term view with regards to asset management. One specific example of this philosophy is the portfolio manager’s current top pick: “…the largest holding in the strategy today is Samsung Electronics (KRX:005930). We talked about this in our fourth-quarter 2014 commentary. We highlighted the investment case and compared it to a combination of Apple (NASDAQ:AAPL), Micron (NASDAQ:MU) and Whirlpool (NYSE:WHR), but at one-fifth the price…it still trades at less than 7 times earnings, 5 times if you pull the cash out.”
While value is a core component of Mr. Crespo’s portfolio management style, he does not let it blind him to the pitfalls of only looking at prior performance. A sector that he is particularly cautious about is healthcare and specifically US based pharmacy benefit managers:
“I think it has gotten to a point where if consumers have to pay for medicines at the same rate that it costs you to buy a Ferrari, that’s going to be a social issue, right? I mean, I don’t think it requires you to have a Ph.D. in physiology to know that.”
To get the entire in-depth exclusive interview with Mr. Crespo, read it in the Wall Street Transcript.
Mohan Naidu of Oppenheimer & Company Bangs the Table for Healthequity (NASD:HQY)
October 06, 2017
Wedbush Managing Director Dr. David Nierengarten Bangs the Table for His Gene Therapy Stock Winners
October 02, 2018
Interview Highlights: Sean M. Thorpe of Aristotle Capital Management on Investing Strategies
August 17, 2016
Gregory Padilla of Aristotle Capital Bullish on Selected Japanese Equities
August 08, 2017
